Hepatitis C in Brazil: lessons learned with boceprevir and telaprevir

In 2012, the first-generation protease inhibitors telaprevir (TVR) and boceprevir (BOC) were introduced in the Brazilian health system for treatment of chronic hepatitis C, after their approval by the National Committee for Health Technology Incorporation (CONITEC). However, these medicines were dis...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Rev Inst Med Trop Sao Paulo
Главные авторы: Gomes, Lenyta Oliveira, Teixeira, Marina Rodrigues, da Rosa, Júnior André, Feltrin, Alberi Adolfo, Rodrigues, João Paulo V., Vecchi, Mariane D’Avila, Carneiro, Jane Meire M., Noblat, Lúcia de Araújo C. B., Chachá, Silvana Gama F., Martinelli, Ana de Lourdes C., Pereira, Leonardo Regis L., Silveira, Marysabel Pinto T., Blatt, Carine Raquel, Farias, Mareni Rocha
Формат: Artigo
Язык:Inglês
Опубликовано: Instituto de Medicina Tropical 2018
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6029893/
https://ncbi.nlm.nih.gov/pubmed/29972466
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/S1678-9946201860029
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы